2023 Was a tough 12 months for the biopharma marketplace, with a number of corporations downsizing and restructuring their workforces to remain afloat. You can find indications of Restoration, as mergers and acquisitions picked up over the pharmaceutical and everyday living sciences business inside the latter Section of 2023 and https://sites.google.com/view/bio-sites/blog